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                                                    ABSTRACT 
 
Varicella-Zoster virus (VZV) is a pathogenic human herpesvirus that causes varicella 
(chickenpox) as a primary infection following which it becomes latent in ganglionic neurons. 
Following viral reactivation many years later VZV causes herpes zoster (shingles) as well as 
a variety of other neurological syndromes. The molecular mechanisms of the conversion of 
the virus from a lytic to a latent state in ganglia are not well understood. In order to gain 
insights into the neuron-virus interaction we studied virus-induced apoptosis in cultures of 
both highly pure terminally differentiated human neurons and human fetal lung fibroblasts 
(HFL). It was found that (a) VZV DNA did not accumulate in infected human neurons; (b) 
VZV transcripts were present at lower levels at all days studied post-infection in neurons; (c) 
Western blot analysis showed less VZV IE 63 and very little detectable VZV gE proteins in 
infected neurons compared with HFL; (d) lower levels of the apoptotic marker cleaved 
Caspase-3 protein  were detected in VZV-infected neurons compared with HFL, and higher 
levels of the known anti-apoptotic proteins  Bcl2 , Bcl-XL and also the mitochondrial MT-
CO2 protein  were found in VZV infected neurons compared to uninfected cells; (e) both the  
MT-CO2  protein and VZV IE 63-encoded protein were detected in infected neurons by dual 
immunofluorescence. These findings showed that neurons are resistant to VZV-induced 
apoptosis, which may have relevance to the switching of VZV from a lytic to latent 















                                                 INTRODUCTION 
 
Varicella-Zoster virus (VZV) is a human neurotropic alpha herpesvirus that causes varicella 
(‘chicken pox’) as a primary infection following which it is converted to a latent state within 
ganglionic neurons throughout the entire neuroaxis (Kennedy et al 1998, Gilden et al 2011, 
Nagel and Gilden 2013). After an interval that may be decades, the virus may reactivate, 
either spontaneously or after various triggering factors, to cause herpes zoster (‘shingles’) 
which is an extremely  painful dermatomal rash that may be followed in some cases by post-
herpetic neuralgia which is typically very refractory to treatment (Gilden et al 2011, Kennedy 
and Gershon 2018). VZV reactivation may also cause a wide variety of other acute, subacute, 
and chronic infections of the nervous system (Kennedy 2011, Nagel and Gilden 2013). An 
understanding of both the lytic and latent behavior of VZV in human neurons is therefore of 
clinical as well as biological importance.  
 
One factor that could play a role in the shift between acute lytic viral infection of neuronal 
cells and the subsequent latent VZV infection of ganglionic neurons is the extent of 
apoptosis, or programmed cell death (Wyllie 1997), that the virus may induce in neurons 
during acute infection. Apoptosis may be induced by various viral infections resulting in 
disruption of normal cellular functions (Kennedy 2015).  However, some viruses, such as 
Herpes simplex virus type-1 (HSV-1) have the capacity to inhibit host cell apoptosis so that 
virus infection is not limited by cell death, thereby allowing viral spread and either viral 
persistence or latency, thus favoring the virus rather than the host. Apoptosis may occur via 
the intrinsic pathway occurring in the mitochondrion with release of cytochrome c leading to 
activation of caspase 9, then caspase 3 with cleavage of DNA (Aubert et al 2007, Kennedy 
2015), or via the extrinsic pathway which uses the Fas ligand (Fas L) leading to cleavage of 
procaspase-8 resulting in activation of caspase-3 and cleavage of cellular DNA (Thornberry 
1997, Aubert et al 2007, Kennedy 2015). Thus, in both pathways the presence of caspase-3 
may be utilized as a marker of apoptosis.  There is evidence that VZV is able to induce 
apoptosis in susceptible cells via both the intrinsic and extrinsic pathways (James et al 2012).  
Since virally-induced phagocytosis of an apoptotic host cell has recently been recognized as 
anti-inflammatory (Kennedy 2015), it is also important to recognize that these various 





The current availability of highly pure (>95%) terminally differentiated human neurons in 
culture, as well as established cell biological techniques and robust markers of apoptosis, now 
allows a detailed analysis of the extent to which VZV has the capacity to induce apoptosis in 
human neuronal cells. We report here the results of our investigation of this process using 
these cellular and molecular tools. 
 
 
                               MATERIALS AND METHODS 
 
Cells 
iCell neurons (Cellular Dynamics International, Madison, WI) were the same as previously 
described in detail (Yu et al 2013) and were derived from induced pluripotent stem cells.  
They were comprised of a combination of post-mitotic neural subtypes with typical 
physiological characteristics and responses, and which showed positive staining with multiple 
neuronal markers. Human fetal lung fibroblasts (HFLs) were cultured in Dulbecco's 
minimum essential medium (DMEM) containing 100 U/ml penicillin and 10 μg/ml 
streptomycin supplemented with 10% fetal bovine serum (FBS). 
 
Virus Infection 
This was carried out as previously described (Yu et al 2013).  Neurons (~1 × 10
6
) were 
infected with 1000 plaque forming units (pfu) of attenuated VZV (Zostavax, Merck, 
Whitehouse Station, NJ) in iCell complete maintenance medium. Human fetal lung 
fibroblasts (HFL) functioned as control cultures in these experiments and were similarly 
infected with 1000 pfu VZV and maintained in DMEM supplemented with 2% FBS. 
 
Total nucleic acid extraction 
Total nucleic acid was extracted using the mirVANA miRNA extraction kit (Ambion, Austin, 
TX). Briefly, cells were scraped in lysis buffer (Ambion) using a rubber policeman. If 
present, visible cell clumps were homogenized using a 17–26-gauge needle  with a 1-ml 
syringe (12–20 strokes) and kept on ice for 10 min. Total nucleic acid was extracted with 
acid-phenol chloroform and applied to an affinity column, washed three times, and eluted in 




Quantitative real-time PCR 
Total nucleic acid was examined by quantitative real-time PCR (RT-qPCR) with VZV-
specific primers (IDT, Coralville, IO) on an Applied Biosystems Fast 7500 and analyzed 
using Fast 7500 software (Yu et al., 2013). Samples were denatured at 95°C and allowed to 
elongate and anneal for 40 cycles at 95°C for 15 s and at 60°C for 30 s. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) primers and probe were used as an expression control.  
 
RNA extraction, cDNA synthesis and RT-qPCR 
Total nucleic acid (200 ng) was DNase-treated using a Turbo-DNA free kit (Ambion) for 30 
min at 37°C, followed by inactivation using inactivation buffer (Ambion) for 5 min at room 
temperature with mixing. Sequestered DNase was pelleted by centrifugation at 2000 rpm for 
5 min and the supernatant was transferred to a new tube. cDNA synthesis was completed 
using the Transcriptor First-Strand cDNA synthesis kit (Roche, Indianapolis, IN). Anchored 
oligo-[dT] and random hexamer primers were added and annealed for 10 min at 65°C to 
ensure high conversion of mRNA to cDNA. After primer annealing, dNTPs, reverse 
transcriptase (RT) reaction buffer and RNase inhibitor were added. Samples were divided 
into 2 portions with and without RT to control for any residual DNA. cDNA was stored at 
0°C. Both RT-positive and -negative samples were amplified along with wild-type VZV 
DNA (106 to 100 genome copies) to compare transcription levels to residual DNA levels. 
VZV primers and Taq Universal Probes superscript ROX mix, (Bio-Rad, Hercules, CA) were 
combined with 2 μl of cDNA and added to a MicroAmp 96-well plate. Quantitative real-time 
PCR was performed as described above. GAPDH primers and probe were used as a cellular 




VZV infected neurons at 14 DPI and HFL at height of CPE as well as uninfected cells were 
used for total protein extraction. The cell culture medium was removed, adherent cells were 
washed with 1X PBS and M-PER® Mammalian Protein Extraction Reagent (Thermo 
Scientific) was added.  Cells were incubated for 5 minutes with gentle agitation, and then 
scraped with a cell scraper.  The lysate was collected and mixed with 1X Complete Mini 
EDTA-Free Protease Inhibitor (Roche), then centrifuged at 14,000 x g for 5 minutes and the 




Western Blot  
Bio-Rad Mini-protean TGX 4-20% Gels (Bio-Rad) were used for SDS-PAGE analysis with 
1X Tris/Glycine/SDS buffer (Bio-Rad). Protein samples (1-5ug/well) were denatured by 
incubation with 1X lane marker reducing sample buffer containing dithiothreitol (Thermo 
Scientific) at 95°C for 10 min. Gels were electrophoresed for 40 min under constant voltage 
of 150 V. The gel was then electro-blotted onto a PVDF membrane (Bio-Rad) for 50 min 
under constant voltage of 10 V using Trans-Blot® Semi-Dry Cell (Bio-Rad). After blocking 
with 6% milk in TBS/0.1% Tween 20 for 1 h, membranes were probed with primary 
antibodies (1:100 to 1:10,000) (Table 1) in 1% milk/TBS/0.05% Tween 20 for 1 hour or 
overnight, then washed once with 0.05% TBST for 10 min, followed by four more washes at 
5 min each. Membranes were then incubated with secondary antibodies (1:2,000-1:20,000) in 
1% milk/TBS/0.05% Tween 20 for one hour, washed five times as before, then incubated 
with SuperSignal® West Femto Maximum Sensitivity chemiluminescent substrate (Thermo 
Scientific) as recommended by the manufacturer. The FluorChem Q™ system was used to 
measure the band intensity of the western Blots. 
 
Immunocytochemistry 
Assays were carried out at 14 days post infection (DPI). Coated coverslips used for neuron 
propagation were obtained from BD Biosciences (San Jose, California). Cells were fixed in 
4% paraformaldehyde for 20 min at room temperature, washed three times in PBS, and 
permeabilized in 0.3% Triton for 10 min. After three rinses with PBS, cells were either 
stained or stored at 4°C in PBS. Primary (anti MTCO2 and anti- VZV IE 63) and secondary 
Alexa-fluor-conjugated (Invitrogen, Grand Island, NY) antibodies were sequentially added 
followed by rocking for 1 h at room temperature after each addition. After 3 washes with 
PBS, coverslips were sealed using mounting media containing DAPI (Vectashield, Vector 
Labs, Burlingame, CA) and visualized on an Eclipse E800 microscope (Nikon, Melville NY) 
(Yu et al., 2013).  
 
 








                                                                  RESULTS 
Highly pure human neurons were used for the study (Yu et al., 2013). iCell neurons were 
obtained in frozen vials, plated onto 6-well cell culture plates freshly coated with a base layer 
of poly-L-ornithine and a top layer of mouse laminin, and maintained in complete iCell 
neuron maintenance medium for up to 21 days. To ensure the purity of neurons used, we 
carry out immunocytochemistry of the cells with neuronal marker anti-βIII tubulin after each 
new vials of cells were plated. Figure 1 demonstrates the purity of neurons at day 14 in 
culture by dual immunofluorescence staining anti-βIII-tubulin antibody and anti-GFAP 
antibody.  
 
After 1–3 days in tissue culture and before VZV infection (day 0), neurons exhibited a 
homogeneous morphology, and more than 95% cells stained positive with neuronal marker 
anti-βIII tubulin (Yu et al., 2013). 
 
1)  VZV DNA (ORFs 9 and 63) did not accumulate in infected human neurons compared with 
human fetal lung fibroblasts (HFL).   
 
Using quantitative real-time PCR with DNA extracted from VZV-infected cells, we showed 
that both ORFs 63 and 9 did not accumulate in neurons whereas they did in HFL (see Figure 
2). We carried out standard curves for each set of primers/probes used for qPCR. The PCR 
efficiency was between 92-95%. ORF 9 is a highly expressed VZV gene during acute lytic 
infection (Kennedy et al 2005), and ORF 63 is an immediate early gene that is the most 
highly expressed VZV gene during latency (Mitchell et al 2003, Kennedy et al 2015). At 7 
DPI it can be seen from the figure that there was a large increase in both VZV ORFs in HFLs 
but not in neuronal cells. Specifically, for ORF9 there was more than a 7- fold change at 14 
DPI in HFL compared with neurons. In the case of ORF 63 there was more than a 4-fold 
change at 12DPI in HFL compared with that seen in neurons. Further, as has been previously 
described (Baird et al 2014b) no VZV-induced cytopathic effects (CPE) were observed at any 
time point. 
 
2. Time course experiments showed that VZV transcripts were present at lower levels at all 




The results of these experiments are shown in Figure 3 which shows the copy numbers over a 
14 DPI period for IE 62 (A), ORF 33(B) and ORF 14 (C). For all three transcripts the copy 
numbers are lower in neurons compared with HFLs. The transcript increases occurred at 
3DPI in HFLs whereas the increases occurred at 7 DPI in the case of infected neurons. In all 
three cases the copy numbers were less in HFL compared with neurons at the various time 
points with the final time of comparison being at 12 DPI. 
 
3. Western blot analysis of infected cultures showed less VZV IE 63 protein in neurons 
compared with HFL and lower levels of VZV gE in neurons compared with abundant levels 
in HFL. 
 
The results of these Western blot analyses are shown in Figure 4. It can be seen that when the 
signals for VZV IE 63 protein were detected on the blot for both neurons and HFLs, though 
this protein was detected in both cell types, nevertheless the abundance of this protein was 
much greater in HFL compared with neuronal cells. When the signals for VZV gE were 
examined there was a far greater abundance of this protein in HFLs than in neurons in which 
much lower levels detected. Notice that the total protein loaded for WB was 6 µg for neurons 
and 1 µg for HFL.  
 
4. Western blot analysis demonstrated lower levels of Caspase 3 protein in VZV-infected 
neurons compared with HFL, and higher levels of anti-apoptotic proteins in VZV infected 
neurons compared to HFL and uninfected cells.  
 
The results of this Western blot analysis are shown in Figure 5.  Table 1 lists the primary 
antibodies and dilutions used. Infected (+) and uninfected (-) cell lysates were separated by 
SDS-PAGE, blotted, and detected with respective primary antibodies (top blots) with ß actin 
as loading control (lower blots). When the band intensity of the targeted proteins was 
measured & normalized with a ß actin control, the relative levels (infected to uninfected) 
were shown as bar graphs for each protein. It can be seen that Caspase-3, a marker of 
apoptosis, was barely detected in VZV-infected neurons but was detected in infected HFL, 
and this is quantified in the bar graph which shows the relative levels of caspase 3 to IE 63. 
By contrast, higher levels of the anti-apoptotic proteins Bcl2 (B), Bcl-XL (C) and also the 
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mitochondrial protein MT-CO2 (D) were detected in infected neurons vs uninfected neurons, 
compared with HFL. 
 
 
5. Immunofluorescence staining demonstrated the presence of both the mitochondrial protein 
MT-CO2 and VZV IE 63-encoded protein in infected neurons. 
 
In view of the above Western blot results in which three different anti-apoptotic proteins had 
been detected in higher levels of VZV-infected neurons (vs uninfected cells), it was important 
to confirm this by demonstrating the presence of MT-CO2 protein within infected neuronal 
cells co-expressing a key VZV-encoded protein IE63. Accordingly, dual 
immunofluorescence was used to demonstrate the co-expression of MT-CO2 and VZV IE 63-
encoded protein in infected neurons (14 DPI), and this result is shown in Figure 6. 
                                         
 
                                            
                                                DISCUSSION 
 
We have shown in this study that VZV-induced apoptosis does occur but is cell-type specific. 
Highly pure terminally differentiated human neurons derived from induced 
pluripotent stem cells were resistant to apoptosis, as evidenced by several established criteria, 
while human fetal lung (HFL) (control) cells were highly susceptible to virally-induced 
apoptosis. These observations may be biologically significant since following an acute 
infection VZV establishes a latent infection in human ganglionic neurons, a state that would 
be unlikely to develop if the initial infection of neurons led to the widespread cell death of 
these cells via apoptotic pathways. Thus, apoptosis of neurons would favour the host since 
the productive infection would be limited, whereas an apoptosis- resistant neuronal 
population would favour the virus and could be a key factor leading to viral latency (Kennedy 
2015). VZV-induced apoptosis has also been shown to be cell-type specific as it has been 
shown, for example, in fibroblasts but not neurons in one previous study (Hood et al. 2003). 
 
Our results are broadly consistent with several previous studies of VZV infection of neuronal 
cells, the findings of which we have now extended. We noted a lack of accumulation of VZV 
DNA in neuronal cells (Baird et al 2014b) as opposed to control HFL. This may contribute to 
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the lack of neuronal susceptibility to VZV infection as well as the absence of an observable 
cytopathogenic effect. A similar lack of susceptibility of neurons to acute infection has also 
been documented in the case of HSV-1 infection of human neural cells (Kennedy et al 1983).  
In the current study, during kinetic analysis of the VZV transcripts, IE 62, ORF 33, and ORF 
14 were all detected in VZV-infected neurons, consistent with previous studies, but the copy 
numbers of these transcripts were lower than in HFL at all time points analysed following 
virus infection. Although there is a difference in the transcripts tested (ORF 62, ORF33, ORF 
14) between the infected neurons and HFL, there is no statistical significance was found. 
Perhaps one can reach a statistical difference if larger group of VZV transcripts are tested in 
multiple replicates over more time points. However, it is known that all VZV genes are 
transcribed and VZV proteins from all kinetic classes are translated in neurons during VZV 
infection, so defective virus transcription does not account for the lack of cell death in VZV-
infected neurons in vitro (Baird et al 2014a). 
 
It was also important to study VZV translation following viral infection in neuronal and HFL 
cultures. Western blot analysis was therefore used to achieve this, and as expected VZV IE 
63-encoded protein was detected in neurons (Mahalingam et al 1996), though in lower 
abundance than was found in HFL, consistent with the more productive acute infection of the 
latter cells. This protein is of particular importance as ORF 63 is the most consistently 
transcribed VZV gene in VZV latency (Kennedy et al 2000, Mitchell et al 2003). It was 
perhaps surprising that the early-late VZV gE glycoprotein (ORF68 translation) was barely 
detected in infected neurons, though it was easily detected in HFL, since this protein has been 
previously described as being abundant in VZV-infected neurons (Grose et al 2013). Possible 
explanations for this discrepancy, which are not mutually exclusive, include the low levels of 
VZV DNA in infected neurons, the detection limits of the assay and a partial viral post-
transcriptional block in neuronal cells. 
 
Western blot analysis also demonstrated low levels of caspase-3, a reliable marker of 
apoptosis in virally infected neurons, though it was present in the more susceptible HFL. This 
was key evidence for the inferred resistance of neurons to VZV-induced apoptosis. This 
absence of apoptotic markers confirms the results of previous studies in such purified VZV-
infected neuronal cultures (Pugazhenthi et al 2011, Yu et al 2013). It was also important to 
show that neurons expressed anti-apoptotic markers to strengthen our underlying 
interpretation of our data.  Indeed, the two known anti-apoptotic proteins studied , Bcl-2, Bcl-
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XL as well as MT-CO2 ( mitochondrially encoded cytochrome c oxidase II, a key subunit of 
cytochrome c oxidase, which is the terminal enzyme involved in the oxidative 
phosphorylation complexes) were found to be upregulated in VZV-infected neurons 
compared with uninfected cells and HFL in which all of these apoptotic proteins were 
downregulated. In a previous study of VZV infection of MeWo cells it was also found that 
the anti-apoptotic protein BCL-2 was downregulated while apoptotic markers such as cleaved 
caspase-3 were present (Brazeau et al 2010). These results were strengthened by our 
observation using two-fluorochrome immunofluorescence that mitochondria in infected 
neurons co-expressed the presumed anti-apoptotic mitochondrial protein MT-CO2 and VZV 
IE 63-encoded protein demonstrating that the neuronal cells known to be virally infected also 
had a key marker of resistance to apoptosis. 
 
The ability of another herpes virus, HSV-1, to inhibit neuronal apoptosis is highly relevant to 
our current findings with VZV.  Thus, it was first shown in 2000 that the latency-associated 
transcript (LAT) gene of HSV-1 promotes neuronal survival after HSV-1 infection by 
reducing apoptosis in the trigeminal ganglia of latently infected rabbits ( Perng et al 2000). 
Following this seminal observation, further understanding of the actual mechanism of HSV-1 
inhibition of apoptosis has been gained, particularly from the laboratories of Jones and 
Wechsler. For example, it was shown that the HSV 1 LAT inhibited apoptosis and also 
promoted neurite sprouting in neuroblastoma cells following serum starvation by maintaining 
protein kinase B (AKT) levels (Li et al 2010). These findings were then followed by the 
observation that the HSV-1 LAT protects cells against cold-shock-induced apoptosis by 
maintaining phosphorylation of protein kinase B (AKT) (Carpenter et al 2015).  Further, two 
small RNAs encoded within the first 1.5 kilobases of the HSV-1 latency-associated transcript 
were shown to inhibit productive viral infection and cooperated to inhibit apoptosis( Shen et 
al 2009). An elegant study which used an HSV-1 mutant containing an unrelated 
antiapoptosis gene in place of the LAT also strongly supported the notion that LAT's anti-
apoptosis activity is the dominant function that enhances HSV-1's spontaneous reactivation 
phenotype (Jin et al 2007). Furthermore, the viral anti-apoptotic function is not limited to 
human HSV-1 since both Bovine Herpes Virus 1 (BHV-1) and HSV-1 promote survival of 
latently infected sensory neurons, in part by inhibiting apoptosis (Jones 2013). 
 
While the definite significance of neuronal resistance to VZV-induced apoptosis can only be 
inferred at present, we consider it likely that this observation has much relevance to the 
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cascade of molecular events that result in VZV latency. Further experiments will clearly be 
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                                               FIGURE LEGENDS 
 
 
Fig. 1. Highly pure human neurons at day 14 in culture.  Dual immunofluorescence 
staining with anti-βIII-tubulin antibody and anti-GFAP antibody revealed positive staining 
for the neuronal marker tubulin (red), but not for GFAP (green). Nuclei stained blue with 
DAPI.  
 
Fig. 2. VZV DNA did not accumulate in infected neurons. Human neurons and human 
fetal lung fibroblasts were infected with cell-free VZV at time point indicated, and total DNA 
was extracted and detected by qPCR for ORF 63 (A) and ORF 9 (B). Relative quantities of 
VZV DNA, normalized to cell DNA were shown to have consistent levels compared DNA 
detected in HFL.  
 
Fig. 3. Time course of VZV transcripts in infected neurons and HFL.  




Fig. 4. Western Blots detecting IE63 and gE proteins in VZV infected neurons. Total 
protein of infected neurons (6 µg) and HFL (1 µg) were loaded for SDS-PAGE; Western 
blotting was performed, and respective VZV proteins were detected.  
 
Fig. 5. Western blots demonstrating higher levels of anti-apoptotic proteins in VZV 
infected neurons compared to uninfected cells. VZV infected (+VZV) and uninfected (-
VZV) cell lysates were separated and detected with respective primary antibodies (top blot) 
with ß actin as control (lower blot). Band intensity of the targeted proteins was measured and 
normalized with ß actin control, and the relative levels (infected to uninfected) were shown as 
bar graph. A. Caspase-3 (~ 17 kDa) was detected at very low levels in both VZV-infected 
neurons and uninfected neurons, but in abundance in infected HFL. Bar graph shows relative 
level of caspase 3 to IE 63 (see Fig.3). Similar results were shown in our previous report (Yu 
2013) B-D: Higher levels of anti-apoptotic proteins Bcl-2 (B, ~26 kDa), Bcl-XL (C, ~30 
kDa) and MT-CO2 (D, ~22 kDa) are detected in infected neurons compared to uninfected 
neurons, but in HFL an opposite result is shown that higher levels of anti-apoptotic protein 
were present in uninfected HFL. The bar graphs next to the western blots show the 
percentage change between infected and uninfected cells. 
 
Fig. 6. Dual immunofluorescence staining showing mitochondria and VZV IE63 in 
infected neurons (14 DPI). IE63 (A, red) in cytoplasm, mitochondria protein (MT-CO2, B, 
green), C: DAPI staining (nucleus), D: merged image.   
 
 
 
